Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saranya Chumsri

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
The Lancet. Oncology|January 5, 2024
Serum hormone concentrations and individualisation of breast cancer preventionSaranya Chumsri
International Journal of Women'S Health|May 26, 2015
Clinical utilities of aromatase inhibitors in breast cancerSaranya Chumsri
Lancet (London, England)|April 22, 2023
Advancing outcomes of metastatic HER2-positive breast cancerSaranya Chumsri
Annals of Hematology|January 19, 2013
Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostimAnn Zimrin, Saranya Chumsri
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Aromatase inhibitors and breast cancerSaranya Chumsri, Angela Brodie
Lancet (London, England)|December 18, 2019
Carryover effects of aromatase inhibitors in preventionSaranya Chumsri, E Aubrey Thompson
Annals of Translational Medicine|July 21, 2025
Breaking new ground in ductal carcinoma in situ management: the promise of intratumoral messenger ribonucleic acid-2752 and pembrolizumabCiara C O'Sullivan, Saranya Chumsri
Current Opinion in Molecular Therapeutics|August 7, 2008
Cancer stem cell targeted agents: therapeutic approaches and consequencesSaranya Chumsri, Angelika M Burger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Therapeutic implications of leukemic stem cell pathwaysSaranya Chumsri, William Matsui, Angelika M Burger
Future Oncology (London, England)|February 25, 2014
mTOR inhibitors: changing landscape of endocrine-resistant breast cancerSaranya Chumsri, Gauri Sabnis, Katherine Tkaczuk, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
The Lancet. Oncology|January 5, 2024
Serum hormone concentrations and individualisation of breast cancer preventionSaranya Chumsri
International Journal of Women'S Health|May 26, 2015
Clinical utilities of aromatase inhibitors in breast cancerSaranya Chumsri
Lancet (London, England)|April 22, 2023
Advancing outcomes of metastatic HER2-positive breast cancerSaranya Chumsri
Annals of Hematology|January 19, 2013
Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostimAnn Zimrin, Saranya Chumsri
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Aromatase inhibitors and breast cancerSaranya Chumsri, Angela Brodie
Lancet (London, England)|December 18, 2019
Carryover effects of aromatase inhibitors in preventionSaranya Chumsri, E Aubrey Thompson
Annals of Translational Medicine|July 21, 2025
Breaking new ground in ductal carcinoma in situ management: the promise of intratumoral messenger ribonucleic acid-2752 and pembrolizumabCiara C O'Sullivan, Saranya Chumsri
Current Opinion in Molecular Therapeutics|August 7, 2008
Cancer stem cell targeted agents: therapeutic approaches and consequencesSaranya Chumsri, Angelika M Burger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Therapeutic implications of leukemic stem cell pathwaysSaranya Chumsri, William Matsui, Angelika M Burger
Future Oncology (London, England)|February 25, 2014
mTOR inhibitors: changing landscape of endocrine-resistant breast cancerSaranya Chumsri, Gauri Sabnis, Katherine Tkaczuk, et al.
Pageof 10